Literature DB >> 15845570

Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor.

Wan-Tzu Chen1, Chih-Jen Huang, Ming-Tsang Wu, Sheau-Fang Yang, Yue-Chiu Su, Chee-Yin Chai.   

Abstract

BACKGROUND: The objective of this study was to evaluate the relationship of HIF-1alpha expression and tumor angiogenesis, recurrence/distant metastasis, and its value in the prediction of aggressive behavior of gastrointestinal stromal tumor (GIST).
METHODS: Paraffin-embedded specimens from 62 patients with GIST were divided into two groups, low risk (n = 31) and high risk (n = 31) according to the tumor size, mitotic count and proliferating cell nuclear antigen (PCNA) index. We investigated the expression of the HIF-1alpha and analyzed correlation with tumor angiogenesis monitored by expression of vascular endothelial growth factor (VEGF) and tumor microvessel density using immunohistochemical staining. The data were analyzed with chi(2) test or Fisher's exact test and multivariate test.
RESULTS: There were statistically significant differences between high risk (29/31; 93.5%) and low risk (8/31; 25.8%) of GIST in high expression of HIF-1alpha (P<0.0001). In addition, the incidence of recurrence/distant metastasis was significantly higher in cases of high HIF-1alpha expression (12/35; 34.3%) than in cases of low HIF-1alpha expression (1/24; 4.2%)(P = 0.009). Moreover, high VEGF expression (37/43; 86.0%) and microvessel density (30/32; 93.8%) were significantly higher in high HIF-1alpha expression tumors than in low-expression tumors (P < 0.0001).
CONCLUSIONS: Our findings suggest that HIF-1alpha may play an important role in aggressive behavior and tumor angiogenesis in GIST. In addition, high expression of HIF-1alpha was significantly correlated with tumor recurrence/distant metastasis, so it may provide an ancillary prognostic factor for GIST.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845570     DOI: 10.1093/jjco/hyi067

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  31 in total

1.  A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib.

Authors:  K N Ganjoo; V M Villalobos; A Kamaya; G A Fisher; J E Butrynski; J A Morgan; A J Wagner; D D'Adamo; A McMillan; G D Demetri; S George
Journal:  Ann Oncol       Date:  2014-01       Impact factor: 32.976

2.  The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft.

Authors:  Tian-bao Wang; Xiu-qing Wei; Wei-hao Lin; Han-ping Shi; Wen-guang Dong
Journal:  Clin Exp Med       Date:  2011-06-10       Impact factor: 3.984

3.  Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma.

Authors:  Erdenebulgan Batmunkh; Mitsuo Shimada; Yuji Morine; Satoru Imura; Hirofumi Kanemura; Yusuke Arakawa; Jun Hanaoka; Mami Kanamoto; Koji Sugimoto; Masaaki Nishi
Journal:  Int J Clin Oncol       Date:  2010-02       Impact factor: 3.402

4.  The clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer.

Authors:  Seong-Eun Kim; Ki-Nam Shim; Sung-Ae Jung; Kwon Yoo; Joo Ho Lee
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

5.  Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells.

Authors:  Liyuan Li; Yi Lu
Journal:  J Cancer       Date:  2010-09-01       Impact factor: 4.207

6.  Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors.

Authors:  Midori Toda-Ishii; Keisuke Akaike; Yoshiyuki Suehara; Kenta Mukaihara; Daisuke Kubota; Shinji Kohsaka; Taketo Okubo; Keiko Mitani; Kaoru Mogushi; Tatsuya Takagi; Kazuo Kaneko; Takashi Yao; Tsuyoshi Saito
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

7.  Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer.

Authors:  Jie Chen; Su-Jun Zhou; Yun Zhang; Guo-Qiang Zhang; Tian-Zhou Zha; Yi-Zhong Feng; Kai Zhang
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

8.  Hypoxia markers in human osteosarcoma: an exploratory study.

Authors:  Hiroo Mizobuchi; José Manuel García-Castellano; Shaji Philip; John H Healey; Richard Gorlick
Journal:  Clin Orthop Relat Res       Date:  2008-06-05       Impact factor: 4.176

9.  HIF-1alpha determines the metastatic potential of gastric cancer cells.

Authors:  N Rohwer; S Lobitz; K Daskalow; T Jöns; M Vieth; P M Schlag; W Kemmner; B Wiedenmann; T Cramer; M Höcker
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

10.  Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease.

Authors:  J E Bluff; S R Menakuru; S S Cross; S E Higham; S P Balasubramanian; N J Brown; M W Reed; C A Staton
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.